Hans Lennart Rudolf Wigzell, Director at Sarepta Therapeutics, Inc. (SRPT), sold 10,000 shares at $83.51 ($835K) on 2021-03-08, disclosed to the SEC on 2021-03-10.
Seasonal sale ($835k) by Director — this insider has traded SRPT in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| SRPT | SELL | 2023-08-08 | $1.6M | — | Filing → |
| SRPT | SELL | 2020-08-11 | $3.2M | — | Filing → |
| SRPT | SELL | 2020-05-22 | $1.2M | — | Filing → |